AI
BDSI

Analytic Investors’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Analytic Investors’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-36,906
Closed -$444K – 664
2014
Q4 		$444K Buy
+36,906
New +$561K 0.01% 433

Other funds holding BDSI

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Analytic Investors's BDSI Position: Q1 2015 in Review

Analytic Investors sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2015, closing a stake of 36,906 shares — an estimated $444K sold.

Analytic Investors first reported a position in BDSI in Q4 2014 and held it in 1 quarter. The position peaked at $444K in Q4 2014. 147 funds tracked by Wall St. Rank hold BDSI as of Q1 2015.

  • Analytic Investors reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2015 after selling out during the quarter.
  • Analytic Investors sold 36,906 BioDelivery Sciences International, Inc. shares in Q1 2015, an estimated $444K.
  • Analytic Investors first reported a position in BioDelivery Sciences International, Inc. in Q4 2014 and held it in 1 quarter.
  • Analytic Investors's BioDelivery Sciences International, Inc. position peaked at $444K in Q4 2014.
  • 147 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2015.

Based on Analytic Investors's 13F filing for Q1 2015, filed 21 May 2015.